There are more than 2 million people in the United States who have profound hearing loss. Most profoundly hearing-impaired people do not benefit from traditional hearing aids. Cochlear implants may provide these individuals with an alternative to deafness.

The Ruch Cochlear Implant program provides state-of-the-art technology to severe-to-profoundly hearing impaired patients.

Thomas J. Haberkamp, MD, is medical director of the Rush Cochlear Implant Program, a joint venture of the Department of Otolaryngology and the Section of Communicative Disorders and Sciences. The team includes medical specialists as well as audiologists, all of whom hold master¿s or doctoral degrees and a certificate of competence from the American Speech-Language-Hearing Association.